Entering text into the input field will update the search result below

Number Of Patients Treated With Start Fresh Program Rises Sharply

Sep. 22, 2014 9:54 AM ETBICX
adbeeston profile picture
adbeeston's Blog
2 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

​Addiction treatment company, BioCorRx, Inc. (BICX), announced a 111% increase in patients being treated with its Start Fresh Program since July 2014 by independent clinics buoyed by the significant expansion and marketing efforts by the company and the clinics across the nation this past year.

"We are pleased to see an increase of this magnitude. This is not only impactful for the financials of BioCorRx Inc., but also for the families receiving the effective help they need to get them on the road to recovery" stated CEO Kent Emry.

In 2014 BioCorRx, Inc. secured license agreements for ten additional states and direct distribution deals with clinics in two other states owned by Dr. George Fallieras. Currently, there are nine clinics open serving patients using the Start Fresh Program, compared to just one operating clinic this time last year. By year-end, at least three new clinics should be opening according to information provided to the company by licensees and Dr. Fallieras.

News of the increase in patients seeking the Start Fresh Program comes at a poignant time as this September marks the 25th annual National Recovery Month by Substance Abuse and Mental Health Services Administration (SAMHSA). The focus of Recovery Month is to positively promote prevention, treatment and recovery of mental and substance use disorders.

"BioCorRx, Inc. is proud to be an integral part of the community assisting families with recovery from addiction. We agree wholeheartedly with SAMHSA's stance that treatment is effective and people do recover" says Emry.

At the same time, BioCorRx announced plans to host its first shareholder conference call on October 15 at 11:00 am Pacific Standard Time to discuss its operations for year to date and outlook for the remainder of this year and 2015. Call in details will be provided at a later date via a follow up press release, but interested parties can assure they will not miss the call in details by visitinghttp://bicxcorp.com/get-updates/ to request updates.

Chief Operating Officer Brady Granier explained that BioCorRx is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh Program consisting of two components used by various addiction clinics in the U.S.

"Our program treats the physical and the psycho-social aspect of one's addiction in a program that typically lasts 6-8 months. The length of the program can be tailored to the individual and done in a completely private, outpatient setting. The first phase of the program consists of an outpatient procedure performed by a licensed physician in which a specially compounded formula of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, is inserted in the lower abdominal area under the fatty tissue. Over the course of several months the implant releases therapeutic levels of Naltrexone, eliminating non-compliance issues commonly found with the use of Naltrexone in oral form. Once the procedure is completed, the patient enters the second phase which entails our one on one coaching program that is specifically tailored to the individual. The clinics that use our program report extremely high success rates with those that complete the entire program. The implant is a tool in the beginning, but the coaching program is where they develop the skills to maintain long term sobriety," added Granier.

For more information on BICX, visit www.BICXCorp.com.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You